In many disinfecting wipes, the active ingredients include quaternary ammonia compounds, or quats for short. They’re ...

Consumer products giant Clorox (NYSE ... was also 33.6% above analysts’ consensus estimates. Is now the time to buy Clorox? Find out in our full research report. Revenue: $1.76 billion vs ...

Fortis Healthcare’s (FORH ... adjusted for Agilus stake. Maintain ‘Buy’ rating with revised TP of Rs710/share, valuing the hospital segment at 26x and diagnostic at 25x EV/EBITDA on FY27E.

We retain our BUY rating on the stock, with an unchanged Sep-25E TP of Rs 2,400 (basis DCF), implying FY26E PER of 55x (in line with LTA).

TD Cowen upgraded Clorox (CLX) to Hold from Sell with a price target of $170, up from $155. The company’s fiscal 2025 guidance now ...

Tenet Healthcare (THC) is a stock many investors are watching right now. THC is currently sporting a Zacks Rank of #1 (Strong Buy) and an A for Value. THC is also sporting a PEG ratio of 0.74.

The Clorox Company’s CLX shares have risen 3.8% in the past week following its robust first-quarter results and raised earnings per share (EPS) view for fiscal 2025. Also, the company has made a ...

In a report released on November 4, Douglas Miehm from RBC Capital maintained a Buy rating on DRI Healthcare (DHT.UN – Research Report), with a price target of C$17.00. The company’s shares ...

The Clorox Company’s CLX shares have risen 3. ... Minerals and Supplements unit in its entirety to an affiliate of Piping Rock Health Products, LLC. This divestiture, coupled with the sale ...